A trial of flutiform in asthma patients in China

Trial Profile

A trial of flutiform in asthma patients in China

Phase of Trial: Phase III

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Mar 2017 According to a Vectura media release, this study is planned to initiate in H2 2017.
    • 02 Dec 2016 New trial record
    • 22 Nov 2016 According to a Vectura Group plc media release, Mundipharma plans to start this trial once approval is obtianed from the Chinese Food and Drug Administration (CFDA).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top